Heron Therapeutics (HRTX) Scheduled to Post Earnings on Tuesday

Heron Therapeutics (NASDAQ:HRTX) is set to release its earnings data before the market opens on Tuesday, November 12th. Analysts expect Heron Therapeutics to post earnings of ($0.03) per share for the quarter. Persons that are interested in registering for the company’s earnings conference call can do so using this link.

Heron Therapeutics Price Performance

HRTX opened at $1.75 on Friday. The company has a market cap of $265.42 million, a price-to-earnings ratio of -5.47 and a beta of 1.81. The firm has a 50 day simple moving average of $1.87 and a 200 day simple moving average of $2.55. Heron Therapeutics has a fifty-two week low of $0.50 and a fifty-two week high of $3.93.

Analyst Upgrades and Downgrades

Separately, Needham & Company LLC reaffirmed a “buy” rating and issued a $5.00 target price on shares of Heron Therapeutics in a research note on Wednesday, September 25th.

Heron Therapeutics Company Profile

Heron Therapeutics, Inc, a commercial-stage biotechnology company, focuses on enhancing the lives of patients by developing and commercializing therapeutic that enhances medical care. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration.